Dipeptidyl Peptidase 3, a Biomarker in Cardiogenic Shock and Hopefully Much More

This publication has 9 references indexed in Scilit:

• Absence of Dipeptidyl Peptidase 3 Increases Oxidative Stress and Causes Bone Loss
  Journal of Bone and Mineral Research, 2019
• Circulating Dipeptidyl Peptidase 3 is a Myocardial Depressant Factor: Dipeptidyl Peptidase 3 Inhibition Rapidly and Sustainably Improves Haemodynamics
  European Journal of Heart Failure, 2019
• Lactate and other biomarkers as treatment target in cardiogenic shock
  Current Opinion in Critical Care, 2019
• Adrenomedullin in Heart Failure: Pathophysiology and Therapeutic Application
  European Journal of Heart Failure, 2018
• Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association
  Circulation, 2017
• Novel Therapeutic Role for Dipeptidyl Peptidase III in the Treatment of Hypertension
  Hypertension, 2016
• Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
  New England Journal of Medicine, 2012
• A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats
  Life Sciences, 1981
• HEMODYNAMIC ALTERATIONS IN ACUTE MYOCARDIAL INFARCTION. I. CARDIAC OUTPUT, MEAN ARTERIAL PRESSURE, TOTAL PERIPHERAL RESISTANCE, “CENTRAL” AND TOTAL BLOOD VOLUMES, VENOUS PRESSURE AND AVERAGE CIRCULATION TIME 12
  Journal of Clinical Investigation, 1952